Clinicopathologic analysis of peripheral T-cell lymphoma, follicular variant, and comparison with angioimmunoblastic T-cell lymphoma: Bcl-6 expression might affect progression between these disorders

American Journal of Clinical Pathology

Volumn 137, Issue 6, 2012, Pages 879-889

  Miyoshi, Hiroaki ^a   Sato, Kensaku ^a   Niino, Daisuke ^a   Arakawa, Fumiko ^a   Kimura, Yoshizo ^a   Kiyasu, Junichi ^a   Takeuchi, Masanori ^a   Yoshida, Maki ^a   Okada, Yosuke ^a   Nakamura, Yukihiko ^a   Sugita, Yasuo ^a   Ohshima, Koichi ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Angioimmunoblastic T cell lymphoma; Bcl 6; Follicular helper T cell; Follicular T cell lymphoma; Overall survival; Pathology; Peripheral T cell lymphoma

Indexed keywords

CD4 ANTIGEN; CHLORAMBUCIL; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CXCL13 CHEMOKINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; LACTATE DEHYDROGENASE; PIRARUBICIN; PREDNISONE; PROGRAMMED DEATH 1 RECEPTOR; PROTEIN BCL 6; T LYMPHOCYTE RECEPTOR BETA CHAIN; VINCRISTINE; BCL6 PROTEIN, HUMAN; DNA BINDING PROTEIN; LEUKOCYTE ANTIGEN; PDCD1 PROTEIN, HUMAN;

ADULT; AGED; ANGIOIMMUNOBLASTIC T CELL LYMPHOMA; ARTICLE; B LYMPHOCYTE; CANCER CHEMOTHERAPY; CELL INFILTRATION; CELL PROLIFERATION; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; CLINICAL FEATURE; EPSTEIN BARR VIRUS; FEMALE; FOLLICULAR VARIANT PERIPHERAL T CELL LYMPHOMA; GENE REARRANGEMENT; HEPATOSPLENOMEGALY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERGAMMAGLOBULINEMIA; IMMUNOBLAST; IMMUNOHISTOCHEMISTRY; LYMPH NODE BIOPSY; MALE; PERIPHERAL T CELL LYMPHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RASH; T LYMPHOCYTE RECEPTOR GENE; TREATMENT RESPONSE; TUMOR CELL; COMPARATIVE STUDY; DISEASE COURSE; FOLLICULAR LYMPHOMA; GENE EXPRESSION REGULATION; GENETICS; GENOTYPE; IMMUNOBLASTIC LYMPHOMA; KARYOTYPE; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; SURVIVAL; T CELL LYMPHOMA;

AGED; AGED, 80 AND OVER; ANTIGENS, CD; CHEMOKINE CXCL13; DISEASE PROGRESSION; DNA-BINDING PROTEINS; EXANTHEMA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOTYPE; HERPESVIRUS 4, HUMAN; HUMANS; KARYOTYPE; LYMPHOMA, FOLLICULAR; LYMPHOMA, LARGE-CELL, IMMUNOBLASTIC; LYMPHOMA, T-CELL; LYMPHOMA, T-CELL, PERIPHERAL; MALE; MIDDLE AGED; PROGRAMMED CELL DEATH 1 RECEPTOR; SURVIVAL ANALYSIS;

EID: 84863767681     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCPBPNV86VZENGV     Document Type: Article

References (44)

1. Rizvi MA, Evens AM, Tallman MS, et al. T-cell non-Hodgkin lymphoma. Blood. 2006;107:1255-1264. (Pubitemid 43242357)
2. Swerdlow SH, Campo D, Harris NL, et al. World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2008:306-308.
3. de Leval L, Savilo E, Longtine J, et al. Peripheral T-cell lymphoma with follicular involvement and a CD4+/bcl-6+ phenotype. Am J Surg Pathol. 2001;25:395-400. (Pubitemid 32174209)
4. Rüdiger T, Ichinohasama R, Ott MM, et al. Peripheral T-cell lymphoma with distinct perifollicular growth pattern: a distinct subtype of T-cell lymphoma? Am J Surg Pathol. 2000;24:117-122. (Pubitemid 30033404)
5. Hatano B, Fukushima T, Honda M, et al. Peripheral T-cell lymphoma with a nodular growth pattern. Pathol Int. 2002;52:400-405. (Pubitemid 34748223)
6. Jiang L, Jones D, Jeffrey LJ, et al. Peripheral T-cell lymphoma with a "follicular" pattern and the perifollicular sinus phenotype. Am J Clin Pathol. 2005;123:448-455. (Pubitemid 40315087)
7. Ikonomou IM, Tierens A, Troen G, et al. Peripheral T-cell lymphoma with involvement of the expanded mantle zone. Virchows Arch. 2006;449:78-87. (Pubitemid 43995203)
8. Rodríguez-Pinilla SM, Atienza L, Murillo C, et al. Peripheral T-cell lymphoma with follicular T-cell markers. Am J Surg Pathol. 2008;32:1787-1799.
9. Huang Y, Moreau A, Dupuis J, et al. Peripheral T-cell lymphomas with a follicular growth pattern are derived from follicular helper T-cells (TFH) and may show overlapping features with angioimmunoblastic T-cell lymphomas. Am J Surg Pathol. 2009;33:682-690.
10. Streubel B, Tinatzar U, Millheim M, et al. Novel t(5;9) (q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma. Leukemia. 2006;20:313-318. (Pubitemid 43148670)
11. Lachenal F, Berger F, Ghesquières H, et al. Angioimmunoblastic T-cell lymphoma: clinical and laboratory features at diagnosis in 77 patients. Medicine. 2007;86:282-292. (Pubitemid 47415007)
12. Iannitto E, Ferreri AJ, Minardi V, et al. Angioimmunoblastic T-cell lymphoma. Crit Rev Oncol Hematol. 2008;68:264-271.
13. Pellatt J, Sweetenham J, Pickering RM, et al. A single-centre study of treatment outcomes and survival in 120 patients with peripheral T-cell non-Hodgkin's lymphoma. Ann Hematol. 2002;81:267-272. (Pubitemid 36067618)
14. Thorns C, Bastian B, Pinkel D, et al. Chromosomal aberrations in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma unspecified: a matrix-based CGH approach. Genes Chromosomes Cancer. 2007;46:37-44. (Pubitemid 44772870)
15. de Leval L, Rickman DS, Thielen C, et al. The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells. Blood. 2007;109:4952-4963. (Pubitemid 46827794)
16. Iqbal J, Weisenburger DD, Greiner TC, et al. Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma. Blood. 2010;115:1026-1036.
17. Attygalle A, Al-Jehani R, Diss TC, et al. Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10. Blood. 2002;99:627-633. (Pubitemid 34533101)
18. Yu H, Shahsafaei A, Dorfman DM, et al. Germinal-center T-helper-cell markers PD-1 and CXCL13 are both expressed by neoplastic cells in angioimmunoblastic T-cell lymphoma. Am J Clin Pathol. 2009;131:33-41.
19. Dupuis J, Boye K, Martin N, et al. Expression of CXCL13 by neoplastic cells in angioimmunoblastic T-cell lymphoma (AITL): a new diagnostic marker providing evidence that AITL derives from follicular helper T cells. Am J Surg Pathol. 2006;30:490-494. (Pubitemid 43740150)
20. Dorfmann DM, Brown JA, Shahsafaei A, et al. Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphoma. Am J Surg Pathol. 2006;30:802-810. (Pubitemid 44264969)
21. Grogg KL, Attygalle AD, Macon WR, et al. Angioimmunoblastic T-cell lymphoma: a neoplasm of germinal-center T-helper cells? Blood. 2005;106:1501-1502. (Pubitemid 41129622)
22. Qubaja M, Adoin J, Moulin JC, et al. Nodal follicular helper T-cell lymphoma may present with different patterns: a case report. Hum Pathol. 2009;40:264-269.
23. Zhan HQ, Li XQ, Zhu XZ, et al. Expression of follicular helper T cell markers in nodal peripheral T cell lymphomas: a tissue microarray analysis of 162 cases [published online ahead of print February 17, 2011]. J Clin Pathol. 2011;64:319-324. doi:10.1136/jcp.2010.084459. Feb 17, 2011.
24. Niino D, Komohara Y, Murayama T, et al. Ratio of M2 macrophage expression is closely associated with poor prognosis for angioimmunoblastic T-cell lymphoma (AITL). Pathol Int. 2010;60:278-283.
25. Barry TS, Jaffe ES, Sorbara L, et al. Peripheral T-cell lymphomas expressing CD30 and CD15. Am J Surg Pathol. 2003;27:1513-1522. (Pubitemid 37486612)
26. Niino D, Ohsaki K, Arakawa F, et al. Composite T lymphoblastic leukemia/lymphoma and diffuse large B-cell lymphoma: case report. Pathol Int. 2011;61:363-368.
27. Attygalle AD, Kyriakou C, Dupuis J, et al. Histologic evolution of angioimmunoblastic T-cell lymphoma in consecutive biopsies: clinical correlation and insights into natural history and disease progression. Am J Surg Pathol. 2007;31:1077-1088. (Pubitemid 47012305)
28. Mourad N, Mounier N, Brière J, et al. Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials. Blood. 2008;111:4463-4470.
29. Arber DA, Weiss LM. CD10: a review. Appl Immunohistochem. 1997;5:125-140.
30. Cutrona G, Leanza N, Ulivi M, et al. Expression of CD10 by human T cells that undergo apoptosis both in vitro and in vivo. Blood. 1999;94:3067-3076. (Pubitemid 29512712)
31. Nurieva RI, Chung Y, Martinez GJ, et al. Bcl6 mediates the development of T follicular helper cells. Science. 2009; 325:1001-1005.
32. Johnston RJ, Poholek AC, DiToro D, et al. Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation. Science. 2009;325:1006-1010.
33. Riley JL, Jane CH. The CD28 family: a T-cell rheostat for therapeutic control of T-cell activation. Blood. 2005;105:13-21. (Pubitemid 40053057)
34. Chtanova T, Tangye SG, Newton R, et al. T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1/Th2 effector cells that provide help for B cells. J Immunol. 2004;173:68-78. (Pubitemid 38797327)
35. Kim CH, Lim HW, Kim JR, et al. Unique gene expression program of human germinal center T helper cells. Blood. 2004;104:1952-1960. (Pubitemid 39297843)
36. Phan RT, Saito M, Basso K, et al. BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells. Nat Immunol. 2005;6:1054-1060. (Pubitemid 41486191)
37. Tunyaplin C, Shaffer AL, Angelin-Duclos CD, et al. Direct repression of prdm1 by Bcl-6 inhibits plasmacytic differentiation. J Immunol. 2004;173:1158-1165. (Pubitemid 38924291)
38. Ranuncolo SM, Wang L, Polo JM, et al. BCL6-mediated attenuation of DNA damage sensing triggers growth arrests and senescence through a p53-dependent pathway in a cell context-dependent manner. J Biol Chem. 2008;28:22565-22572.
39. Juszczynski P, Chen L, O'Donnell E, et al. BCL6 modulates tonic BCR signaling in diffuse large B-cell lymphomas by repressing the SYK phosphatase, PTPROt. Blood. 2009;114:5315-5321.
40. Wagner SD, Ahearne M, Ferrigno PK. The role of BCL6 in lymphomas and routes to therapy. Br J Haematol. 2011;152:3-12.
41. Logarajah S, Hunter P, Kraman M, et al. BCL-6 is expressed in breast cancer and prevents mammary epithelial differentiation. Oncogene. 2003;22:5572-5578. (Pubitemid 37102692)
42. Yang WC, Collette Y, Nunès JA, et al. Tec kinases: a family with multiple roles in immunity. Immunity. 2000;12:373-382.
43. Bolen JB, Brugge JS. Leukocyte protein tyrosine kinases: potential targets for drug discovery. Annu Rev Immunol. 1997;15:371-404. (Pubitemid 27169286)
44. Feldman AL, Sun DX, Law ME, et al. Overexpression of Syk tyrosine kinase in peripheral T-cell lymphomas. Leukemia. 2008;22:1139-1143. (Pubitemid 351833780)